Jim Simons’s Mateon Therapeutics, Inc. MATN Stock Holding History

Jim Simons’s Portfolio MATN Stock Details MATN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,094,900	Closed	-$679K	–	3634
2016 Q3	$679K	Buy	1,094,900 +49,100	+5%	+$33.3K	﹤0.01%	2716
2016 Q2	$732K	Buy	+1,045,800	New	+$741K	﹤0.01%	2656

Other funds holding MATN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Jim Simons's MATN Position: Q4 2016 in Review

Jim Simons sold out of Mateon Therapeutics, Inc. (MATN) in Q4 2016, closing a stake of 1,094,900 shares — an estimated $679K sold.

Jim Simons first reported a position in MATN in Q2 2016 and held it in 2 quarters. The position peaked at $732K in Q2 2016. 1 fund tracked by Wall St. Rank holds MATN as of Q4 2016.

Jim Simons reported no remaining Mateon Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
Jim Simons sold 1,094,900 Mateon Therapeutics, Inc. shares in Q4 2016, an estimated $679K.
Jim Simons first reported a position in Mateon Therapeutics, Inc. in Q2 2016 and held it in 2 quarters.
Jim Simons's Mateon Therapeutics, Inc. position peaked at $732K in Q2 2016.
1 fund tracked by Wall St. Rank held Mateon Therapeutics, Inc. as of Q4 2016.

Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.